July 24, 2012
Division of Corporate Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 6010
Washington, D.C. 20549
Attention: | Jim B. Rosenberg, Senior Assistant Chief Accountant | |
Joel Parker, Accounting Branch Chief | ||
Tabatha Akins, Staff Accountant |
Re: | Life Technologies Corporation | |
Form 10-K for the Year Ended December 31, 2011 | ||
Filed February 29, 2012 | ||
Form 10-Q for the Quarterly Period Ended March 31, 2012 | ||
Filed May 3, 2012 | ||
Form 8-K Dated February 7, 2012 | ||
Filed February 7, 2012 and Amended February 29, 2012 | ||
File No. 000-25317 |
Ladies and Gentlemen:
This letter is in response to the verbal comment provided on July 13, 2012 by Joel Parker of the Staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) regarding the Form 10-K for the year ended December 31, 2011 (the “Form 10-K”), the Form 10-Q for the Quarterly Period ended March 31, 2012 (the “Form 10-Q”), and the Form 8-K dated and filed February 7, 2012 and amended February 29, 2012 (the “Form 8-K”) of Life Technologies Corporation (the “Company”). This letter restates the comment of the Staff in bold/italic font and in the discussion set forth below each comment is the Company’s response.
1. | Please refer to prior comment 1. Please confirm that gross margin for each business group is not presented in the monthly package reviewed by the CODM and the Company’s leadership team or the financial package presented to the Board of Directors. Please also provide us proposed revised disclosure to be included in future periodic reports that discusses what information is regularly reviewed by the CODM to make decisions about resources to be allocated and assessing performance as this appears to be a key factor used to identify your segment. |
Division of Corporate Finance
United States Securities and Exchange Commission
July 24, 2012
Page 2 of 3
Response:
The Company confirms that gross margin for each of the Company’s reported business groups is not presented in the monthly financial package reviewed by the Company’s Chief Operating Decision Maker (“CODM”) and the financial package presented to the Board of Directors.
The following verbiage represents the Company’s revised disclosure to discuss the information that is regularly reviewed by the CODM to make decisions about resources to be allocated and in assessing performance:
The Company has determined, in accordance withASC Topic 280, Segment Reportingthat the Company operates as one operating segment. The Company’s Chief Operating Decision Maker (CODM) reviews revenue at the business group level and manufacturing, operating income and expenses, and net income at the Company wide level to allocate resources and assess the Company’s overall performance. The Company’s business groups share common, centralized support functions, including finance, human resources, legal, information technology, and corporate marketing, all of which report directly to the CODM. Accordingly, decisions regarding the Company’s overall operating performance and allocation of Company resources are assessed on a consolidated basis.
*****
The Company hereby acknowledges that:
• | The Company is responsible for the adequacy and accuracy of the disclosure in the filings; |
• | Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and |
• | The Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Division of Corporate Finance
United States Securities and Exchange Commission
July 24, 2012
Page 3 of 3
We appreciate the Staff’s attention to the review of the Form 10-K, the Form 8-K, and the Form 10-Q. Please do not hesitate to contact me at (760) 603-6454 if you have any questions regarding this letter.
Sincerely, | ||
LIFE TECHNOLOGIES CORPORATION | ||
By: | /s/ David F. Hoffmeister | |
David F. Hoffmeister | ||
Chief Financial Officer |
cc: | David Szekeres, Life Technologies Corporation | |
Kelli Richard, Life Technologies Corporation |